Prantesh Jain

Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade

Pranjal Vaidya, Kaustav Bera, Pradnya D. Patil et al. · Journal for ImmunoTherapy of Cancer · 2020 · 119 citations · Full text

Medicine, Oncology, Pharmacology +17

NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2024 · 107 citations

Pharmacy, Immunology, Oncology +17

Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features

Mohammadhadi Khorrami, Prantesh Jain, Kaustav Bera et al. · Lung Cancer · 2019 · 73 citations · Full text

Medicine, Oncology, Radiology +16

Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis

Avirup Guha, Daniel Addison, Prantesh Jain et al. · Biology of Blood and Marrow Transplantation · 2020 · 67 citations · Full text

Medicine, Hematology, Oncology +14

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

Ziad Bakouny, Chris Labaki, Punita Grover et al. · JAMA Oncology · 2022 · 62 citations · Full text

Life Sciences, Immunology, Oncology +17